These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8418211)
21. Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A. Cornelissen JJ; Mäkel I; Algra A; Benaissa-Trouw BJ; Schellekens JF; Kraaijeveld CA; Verhoef J J Infect Dis; 1993 Apr; 167(4):876-81. PubMed ID: 8450253 [TBL] [Abstract][Full Text] [Related]
22. Analysis of the immune response to lipopolysaccharide. Existence of an interspecies cross-reactive idiotype associated with anti-lipid A antibodies. Su SD; Ward MM; Apicella MA; Ward RE J Immunol; 1990 Nov; 145(9):2994-3001. PubMed ID: 2212671 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of lipopolysaccharide-associated endotoxin activities in vitro and in vivo by the human anti-lipid A monoclonal antibody SdJ5-1.17.15. Fang IS; Wisniewski MA; Huntenburg CC; Knight LS; Bubbers JE; Schneidkraut MJ Infect Immun; 1993 Sep; 61(9):3873-8. PubMed ID: 8359908 [TBL] [Abstract][Full Text] [Related]
27. Human monoclonal antibody HA-1A binds to endotoxin via an epitope in the lipid A domain of lipopolysaccharide. Bogard WC; Siegel SA; Leone AO; Damiano E; Shealy DJ; Ely TM; Frederick B; Mascelli MA; Siegel RC; Machielse B J Immunol; 1993 May; 150(10):4438-49. PubMed ID: 7683319 [TBL] [Abstract][Full Text] [Related]
29. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli. Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054 [TBL] [Abstract][Full Text] [Related]
30. Human monoclonal antibodies that recognize conserved epitopes in the core-lipid A region of lipopolysaccharides. Pollack M; Raubitschek AA; Larrick JW J Clin Invest; 1987 May; 79(5):1421-30. PubMed ID: 2437155 [TBL] [Abstract][Full Text] [Related]
31. Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Teng NN; Kaplan HS; Hebert JM; Moore C; Douglas H; Wunderlich A; Braude AI Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1790-4. PubMed ID: 3856860 [TBL] [Abstract][Full Text] [Related]
32. Comparison of binding specificity and the function of two human IgM anti-lipid A monoclonal antibodies. Wisniewski MA; Kazemi M; Fang IS; Knight LS; Huntenburg CC; Bubbers JE; Schneidkraut MJ Circ Shock; 1994 Dec; 44(4):230-7. PubMed ID: 7543030 [TBL] [Abstract][Full Text] [Related]
33. The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes. Seelen MA; Athanassiou P; Lynn WA; Norsworthy P; Walport MJ; Cohen J; Davies KA Immunology; 1995 Apr; 84(4):653-61. PubMed ID: 7790040 [TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies that distinguish inner core, outer core, and lipid A regions of Pseudomonas aeruginosa lipopolysaccharide. de Kievit TR; Lam JS J Bacteriol; 1994 Dec; 176(23):7129-39. PubMed ID: 7525538 [TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14. Le Roy D; Di Padova F; Tees R; Lengacher S; Landmann R; Glauser MP; Calandra T; Heumann D J Immunol; 1999 Jun; 162(12):7454-60. PubMed ID: 10358200 [TBL] [Abstract][Full Text] [Related]
36. Preincubation of endotoxin with monoclonal anti-lipid A (E5), but not in vivo treatment, inhibits circulatory dysfunction. Arden WA; Strodel WE; Gross DR; Anderson KW; Oremus R; Derbin M; Schwartz RW Shock; 1995 Aug; 4(2):131-8. PubMed ID: 7496898 [TBL] [Abstract][Full Text] [Related]